Who, When, and How: Navigating Combination Therapies in mCRC
Panelists discuss how managing common toxicities in combination therapies requires specific strategies including dose reductions and growth factor support for…
FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks
The FDA intends to update opioid labels to highlight risks of addiction, overdose, and interactions, enhancing safety in pain management…
FDA Actions to Remove Unapproved Drugs from the Market by Drug
This page lists FDA Actions to Remove Unapproved Drugs from the Market by Drug
Beyond Survival: SUNLIGHT’s Influence on QoL in mCRC
Panelists discuss how the SUNLIGHT trial’s demonstration that adding bevacizumab to trifluridine/tipiracil improves overall survival and progression-free survival represents the…
FDA Grants Birelentinib Fast Track Designation for Patients With Relapsed or Refractory CLL/SLL
Birelentinib gains FDA fast track designation, offering hope for relapsed CLL/SLL patients resistant to current BTK and BCL-2 therapies.
Trump tariff court case questions president’s emergency powers
Appellate judges are weighing dueling interpretations of a 1977 emergency powers act to determine the legality of the Trump administration’s…
Caffeine Consumption Not Associated With Chronic Kidney Disease, Study Finds
The researchers speculate that this is because of the antioxidant and anti-inflammatory properties of coffee and tea.
AIS Healthcare Awarded a Group Purchasing Agreement for 503A Intrathecal Compounded Medications with Premier, Inc.
DALLAS–(BUSINESS WIRE)–AIS Healthcare has been awarded a group purchasing agreement for 503A intrathecal compounded medications with Premier, Inc., effective July…
UnitedHealth and Amedisys reach settlement with DOJ over $3.3B merger
The settlement filed with the Maryland district court on Thursday requires UnitedHealth and Amedisys to divest certain businesses to placate…
BlinkRx Launches “Operation Access Now” to Accelerate and Scale Direct‑to‑Patient and Direct‑to‑Business Programs
NEW YORK–(BUSINESS WIRE)–BlinkRx, the nation’s leading prescription lifecycle management platform, today announced the launch of Operation Access Now, a rapid…